Skip to main content
OpenTrials
Completed

NCT Number: NCT03837405

(R33 Phase) DELISH Study: Diabetes Education to Lower Insulin, Sugars, and Hunger

The investigators plan an R33 phase trial in which 120 persons with type 2 diabetes (T2DM) will be randomized (using a 1:1 ratio) to education alone (Ed) on following a carbohydrate restricted diet for T2DM, or this same education content with added mindful eating/Mindfulness-Based Intervention components (Ed+MBI).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Osher Center for Integrative Medicine

San Francisco, California, 94115, United States

About this study

The investigators will randomize 120 persons with T2DM in a 1:1 ratio to a nutrition education alone arm (Ed n=60) vs. a nutrition education with mindfulness-based intervention components (Ed+MBI n=60) arm and follow them for 12 months. The interventions will be provided in a weekly group setting, with about 10 to 12 persons per group. Some educational intervention components will be delivered using a smartphone app. After the 12-week initial intervention, the investigators will re-randomize participants using an adaptive intervention design to receive low, medium, or high intensity maintenance training, depending on level of adherence achieved during the initial intervention period. Follow-up assessments will be performed at 3, 6, 9, and 12 months. The investigators will address the following specific aims:

  • Test the hypothesis that the Ed+MBI arm will have better dietary adherence than the Ed arm.
  • Test whether our proposed behavioral mechanisms (e.g. decreased eating in response to cravings or difficult emotions) predict dietary adherence.
  • Obtain preliminary assessment of intervention effects on clinical outcomes

This is the second phase of a two-phase study. Pilot testing has been completed in the first phase (R61). The focus of the second phase (R33) is on comparing dietary adherence between the Ed only and ED + MBI arms over a 12-month period. This phase will also include employing an adaptive intervention design in the post-treatment phase to test optimization of the maintenance intervention (i.e. assigning maintenance intensity/dose based on how a participant is doing). The maintenance phase intensities will be assessed to provide preliminary data for planning future trials. The primary analysis focus of this phase will be on the comparing the groups formed by the initial randomization to Ed versus Ed + MBI. The investigators will use fingerstick blood ketone measures, which provide an objective measure of whether the target levels of carbohydrate restriction have been attained, as our primary adherence outcome measure. This will be supplemented by 24-hour diet recall measures of carbohydrate consumption. Important secondary outcome measures will include clinical measures such as glycosylated hemoglobin and behavioral measures such as frequency of eating in response to food cravings.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of T2DM mellitus.
  • HbA1c ≥ 6.5% and < 12.0% at screening.
  • Experience food-related cravings most days of the week and eat in response to these cravings regularly.
  • Aged 18 years old and older.
  • Able to engage in light physical activity.
  • Willing and able to participate in the interventions including appropriate participation in the group setting.
  • Have smartphone and are willing to use it on a regular basis for data collection.
  • Ability to speak English.

Exclusion criteria

  • Unable to provide informed consent.
  • A substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate in the intervention, that may need immediate changes in medical management that will affect study outcome measures, or that may require important adaptations in the study diet.
  • Pregnant or planning to get pregnant in the next 12 months, breastfeeding or less than 6 months post-partum.
  • Current use of weight loss medications, such as Alli or amphetamine-based drugs that may affect weight.
  • Planned or history of weight-loss (bariatric) surgery, or other intestinal surgeries that cause malabsorption. These are likely to change study outcome measures, making it difficult to distinguish the effects of the intervention program, or require extensive tailoring of the diet intervention.
  • Currently enrolled in a weight loss program, such as Weight Watchers or a self-help group such as Overeaters Anonymous, or have unalterable plans to enroll in one of these programs in the next year; using a ketogenic low carbohydrate diet in the past 6 months with advice from a health care professional; or use of a mindful eating program with guidance from a professional in the past 6 months or have ever used the study mindful-eating app.
  • Vegan or vegetarian.
  • Unwilling to do regular blood testing at home for glucose or ketone monitoring.

Treatment and study plan

Carbohydrate-restricted diet

Behavioral

Education for carbohydrate-restricted diet

Mindfuless

Behavioral

Mindful eating app use plus group sessions to learn mindfulness

Primary outcomes

  1. Diet Adherence Between Intervention Arms as Measured by % of Ketones >= 0.5 mmol/L

    Time frame: Measures from ketone measure initiation (week 5) to 12 months. Ketones were measured daily over 7 days at 5 study timepoints: 5 weeks, 3, 6, 9, and 12 months.

    Percent of participant ketone measures > or = 0.5 mmol/L during trial, by study arm

  2. Diet Adherence Between Intervention Arms as Measured by % of Participants in Each Arm With < 50 Grams/Day of Non-fiber Carbohydrate on 24- Hour Diet Recall

    Time frame: Average of three measures, done at 3, 6 and 12 months

    Average percent of participant measures with consumption of < 50 grams/day of non-fiber carbohydrate (from 24-hour diet recall) by arm. Each participant was assigned a % of up to three measures reporting < 50 grams/day of non-fiber carbohydrate consumption, and this percent was averaged across each arm.

Secondary outcomes

  1. Emotion-related Eating

    Time frame: change from baseline to 12 months

    change in emotion-related eating as measured by the Coping subscale of the Palatable Eating Motives Scale (PEMS). The coping subscale ranges from 1 to 5 (based on a mean of 4 items), with higher values indicating more emotion-related eating (the intervention aimed to lower this score--lower scores represent improvement).

  2. Glycemic Control--HbA1c

    Time frame: change from baseline to 12 months

    Change in Hemoglobin A1c from baseline to 12 months with study arm

  3. Frequency of Eating in Response to Cravings

    Time frame: Change from baseline to 12 months

    Frequency of eating in response to cravings (indulgence) using ecological momentary assessment (EMA), operationalized as the percent of solicited occasions when a participant reported eating in response to cravings (rather than in response merely to hunger). Participants received 18 queries about eating in response to cravings over 3 days. Participants had to respond to at least 9 queries to have adequate data completeness for analysis. Frequency of eating in response to cravings is the proportion (scaled as a percent) of queries that participants responded to with responses that reported eating in response to cravings.

  4. Diet Adherence Between Intervention Arms as Measured by Mean Grams of Non-fiber Carbohydrate Consumed Per Day From 24- Hour Diet Recall

    Time frame: From 3 to 12 months, using measures done at 3, 6, and 12 months

    Mean grams of non-fiber carbohydrate consumed per day (from 24-hour diet recall) during trial. We calculated average grams of non-fiber consumed per day across up to three measures during the trial for each participant, and this was averaged across arms.

  5. Salzburg Stress Eating Scale

    Time frame: change from baseline to 12 months

    Change in stress-related eating as measured by Salzburg Stress Eating Scale. Range is from 1 to 5. Higher scores indicate greater stress-related eating.

  6. Weight Change

    Time frame: change from baseline to 12 month weight data

    Body mass in kilograms (kg) from baseline to 12 months

Other outcomes

  1. Stress-related Eating

    Time frame: change from baseline to 12 months

    Change in stress-related eating as measured by two questions about stress-related eating from the MIDUS study and one additional stress-related eating question. Range is 2 to 8. Higher scores indicate more stress-related eating.

  2. Perceived Stress Scale

    Time frame: change from baseline to 12 months

    Change in Perceived Stress Scale total score. Range is 0 to 40. Higher scores indicate more perceived stress.

  3. HOMA-2IR Index of Insulin Resistance

    Time frame: change from baseline to 12 months

    Insulin resistance estimated from the Homeostatic model assessment (HOMA) model 2 index of insulin resistance. The basic formula is: (glucose × insulin) / 22.5, where glucose is measured in mmol/L and insulin in mU/L. The computer assisted re-calibration in model 2 addresses variations in the glucose resistance of the peripheral tissue and liver, increases in the insulin secretion curve for glucose > 180 mg/dL, and contribution of circulating pro-insulin. Higher values indicate more insulin resistance (worse outcome). The Oxford University HOMA-2IR calculator was used (https://process.innovation.ox.ac.uk/software/p/2112/homa2-calculator/1). HOMA index values < 2.0 are generally considered normal and indicate adequate sensitivity of cells to insulin. HOMA index values between 2.0 and 2.5 may indicate borderline changes in insulin sensitivity. HOMA index values > 2.5 clearly indicate insulin resistance.

  4. Fasting Glucose

    Time frame: change from baseline to 12 months

    Glycemic control as measured by fasting blood glucose

  5. Mindfulness: FFMQ

    Time frame: change from baseline to 12 months

    Five-factor mindfulness questionnaire scale (FFMQ). Values represent an overall score summing five sub-scales. Range is 24 to 120. Higher scores indicate greater mindfulness.

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

Registry information

Official study title

Optimizing Lifestyle Interventions With Mindfulness-based Strategies in Type 2 Diabetes

Acronym: DELISH R33

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Feb 12, 2019
Registry last updated
Jun 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.